Charles River Laboratories Operating Income 2010-2025 | CRL

Charles River Laboratories annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Charles River Laboratories operating income for the quarter ending March 31, 2025 was $0.075B, a 40.73% decline year-over-year.
  • Charles River Laboratories operating income for the twelve months ending March 31, 2025 was $0.176B, a 69.4% decline year-over-year.
  • Charles River Laboratories annual operating income for 2024 was $0.227B, a 63.17% decline from 2023.
  • Charles River Laboratories annual operating income for 2023 was $0.617B, a 5.18% decline from 2022.
  • Charles River Laboratories annual operating income for 2022 was $0.651B, a 10.36% increase from 2021.
Charles River Laboratories Annual Operating Income
(Millions of US $)
2024 $227
2023 $617
2022 $651
2021 $590
2020 $433
2019 $351
2018 $331
2017 $288
2016 $238
2015 $206
2014 $178
2013 $151
2012 $166
2011 $174
2010 $-299
2009 $170
Charles River Laboratories Quarterly Operating Income
(Millions of US $)
2025-03-31 $75
2024-12-31 $-168
2024-09-30 $117
2024-06-30 $152
2024-03-31 $126
2023-12-31 $133
2023-09-30 $152
2023-06-30 $165
2023-03-31 $168
2022-12-31 $164
2022-09-30 $151
2022-06-30 $187
2022-03-31 $149
2021-12-31 $173
2021-09-30 $156
2021-06-30 $138
2021-03-31 $124
2020-12-31 $129
2020-09-30 $133
2020-06-30 $77
2020-03-31 $94
2019-12-31 $109
2019-09-30 $93
2019-06-30 $80
2019-03-31 $70
2018-12-31 $102
2018-09-30 $84
2018-06-30 $77
2018-03-31 $68
2017-12-31 $63
2017-09-30 $74
2017-06-30 $82
2017-03-31 $70
2016-12-31 $69
2016-09-30 $59
2016-06-30 $58
2016-03-31 $51
2015-12-31 $52
2015-09-30 $55
2015-06-30 $56
2015-03-31 $43
2014-12-31 $41
2014-09-30 $46
2014-06-30 $51
2014-03-31 $40
2013-12-31 $25
2013-09-30 $41
2013-06-30 $43
2013-03-31 $43
2012-12-31 $35
2012-09-30 $38
2012-06-30 $49
2012-03-31 $44
2011-12-31 $42
2011-09-30 $37
2011-06-30 $53
2011-03-31 $42
2010-12-31 $-365
2010-09-30 $6
2010-06-30 $30
2010-03-31 $30
2009-12-31 $35
2009-09-30 $44
2009-06-30 $51
2009-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical Services $7.559B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.869B 26.80
CVS Health (CVS) United States $84.351B 10.48
Elevance Health (ELV) United States $78.372B 10.11
Cencora (COR) United States $58.632B 20.40
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $21.669B 0.00
Labcorp Holdings (LH) United States $21.584B 17.51
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.511B 0.00
Solventum (SOLV) United States $13.191B 13.96
CochLear (CHEOY) Australia $12.755B 0.00
ICON (ICLR) Ireland $11.919B 11.08
Revvity (RVTY) United States $11.635B 20.02
Viatris (VTRS) United States $10.798B 3.71
Avantor (AVTR) United States $9.206B 13.38
Medpace Holdings (MEDP) United States $9.166B 24.34
HealthEquity (HQY) United States $8.806B 38.57
Sonic Healthcare (SKHHY) Australia $8.474B 0.00
Caris Life Sciences,�Inc (CAI) United States $6.749B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.885B 28.77
BrightSpring Health Services (BTSG) United States $3.868B 35.48
Sotera Health (SHC) United States $3.236B 18.39
Surgery Partners (SGRY) United States $2.823B 36.72
Concentras Parent (CON) United States $2.608B 15.07
Alignment Healthcare (ALHC) United States $2.600B 0.00
Organon (OGN) United States $2.527B 2.69
GeneDx Holdings (WGS) United States $2.446B 94.22
Ardent Health (ARDT) United States $1.902B 8.11
PACS (PACS) United States $1.902B 0.00
Progyny (PGNY) United States $1.839B 40.47
Premier (PINC) United States $1.812B 13.75
GoodRx Holdings (GDRX) United States $1.693B 33.86
Teladoc Health (TDOC) United States $1.416B 0.00
Establishment Labs Holdings (ESTA) $1.333B 0.00
Pediatrix Medical (MD) United States $1.155B 8.79
CareDx (CDNA) United States $1.027B 16.04
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.965B 0.00
AMN Healthcare Services Inc (AMN) United States $0.813B 7.61
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Nutex Health (NUTX) United States $0.698B 10.57
Embecta (EMBC) United States $0.586B 3.95
InnovAge Holding (INNV) United States $0.563B 0.00
LifeMD (LFMD) United States $0.554B 0.00
Omada Health (OMDA) $0.481B 0.00
SBC Medicals (SBC) United States $0.467B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
Auna S.A (AUNA) Luxembourg $0.464B 10.45
So-Young (SY) China $0.436B 0.00
Enhabit (EHAB) United States $0.371B 30.50
Performant Healthcare (PHLT) United States $0.329B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.310B 0.00
Beauty Health (SKIN) United States $0.277B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
DocGo (DCGO) United States $0.155B 25.33
Pheton Holdings (PTHL) China $0.129B 0.00
Sera Prognostics (SERA) United States $0.091B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
OpGen (OPGN) United States $0.051B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00